Advances in Soft Tissue Sarcoma

Soft-tissue sarcomas (STSs) are a heterogeneous collection of rare tumors. As such, they can arise within any site of the body, including the extremities, trunk, retroperitoneum, and head and neck.

The goal of this activity is to provide oncology healthcare providers with knowledge that can be applied to developing a treatment plan for their patients with STS.

Target Audience

This activity is intended for oncology healthcare providers who care for patients with STS. No prerequisites required.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to:

  • IDENTIFY clinical and pathological characteristics of STS and challenges of traditional treatment strategies.
  • EVALUATE the efficacy and safety of first-line STS treatments, including recent changes to clinical practice guidelines.
  • DESIGN a treatment plan for second-line STS therapy, incorporating newly approved agents utilized in various subtypes of STS.
Additional information
Contact email: 
webmaster@asimcme.com
Course summary
Available credit: 
  • 1.00 ANCC
Registration opens: 
12/15/2017
Registration closes: 
12/15/2018
Cost:
$0.00
Part of: 
Journal | Oncology Consult

Chair and Planner
David S. Ettinger, MD
Alex Grass Professor of Oncology
Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland

Faculty Authors
Nita Ahuja, MD
Professor of Surgery, Oncology, and Urology
Johns Hopkins University School of Medicine
Baltimore, Maryland

 

The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Available Credit

  • 1.00 ANCC

Price

Cost:
$0.00
Please login or register to take this course.